Tag: Ferring

Ferring Holding SA, better known as Ferring Pharmaceuticals, is a multinational pharmaceutical company that specializes in the development and marketing of drugs for use in human medicine.

Ferring and MSD completed the Carbetocin Haemorrhage Prevention clinical trial

Ferring Pharmaceuticals and MSD announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program at the World Health Organization.

Ferring Pharmaceuticals will launch a new biotech centre in Switzerland

Ferring Pharmaceuticals is expanding its capabilities in biologics through a new biotech centre which will be installed at the company’s existing headquarters and manufacturing site in Saint-Prex, Switzerland.

Ferring announced a research collaboration with the Chinese Academy of Sciences

Ferring Pharmaceuticals and Chinese Academy of Sciences announced a long-term collaboration to advance basic and translational research in reproductive medicine

Ferring and Ache Laboratorios Farmaceuticos open a joint nanotechnology centre

Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos announced the inauguration of their joint nanotechnology centre in São Paulo, Brazil

Ferring made a development agreement with Alrise Biosystems

Ferring Pharmaceuticals and Alrise Biosystems announced today that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise’s ImSus Technolog...

Ferring and Enteris BioPharma entered License Agreement

Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris’ proprietary...

Ferring localizes the production on Pharmstandart’s site

The global biopharmaceutical company Ferring Pharmaceuticals and the leading Russian pharmaceutical company OJSC “Pharmstandart” have announced the beginning of strategic partnership in the full cycle production of Traktocile (INN atosiban) and Pabal (INN carbetocin) used for the treatment of early labour and prevention of postpartum haemorrhage.